CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Conversion Exec. Vice Chairman/CEO/Pres. acquired 552,500 shares (conversion)
- 4 Conversion CFO acquired 85,000 shares (conversion)
- 4 Other acquisition Director acquired 108,608 shares (other)
- 4 Other acquisition Director acquired 108,608 shares (other)
- 8-K Event Bylaws or fiscal year change
- 8-K Event Shareholder vote results · Other events
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- SC 13D Stake Beneficial Ownership Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G Stake Amended Statement of Ownership
- 10-K Report Annual Report
- 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 13,400 shares at $0.18 ($2,352)
- 8-K Event Material agreement
- 4 Option exercise Director acquired 200,040 shares (option exercise)
- 4 Option exercise Director acquired 200,040 shares (option exercise)
- 4 Option exercise Sr. VP of Operations acquired 50,010 shares (option exercise)
Page 30 of 82 · 1,637 filings